2026 Q2 Portfolio Activity
In 2026 Q2, Tao Capital Management LP maintained a portfolio of 9 distinct positions. The most significant new addition was Space Exploration Technologies, now representing 93.75% of the total fund value. They heavily accumulated shares in 10x Genomics, Inc., increasing the position by 34.4%. The fund also reduced its exposure to Twist Bioscience Corporation by 42.2%.
Position History
hover any row below to update
Loading…
Total Positions
9
Quarter
2026 Q2
Top Holding
N/A (93.7%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-9 of 9
Tao Capital Management LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N/A
Space Explorati...
|
|
Unknown | 93.75% | — |
#1
Prev: #—
|
9.5 |
—
|
10,644,340 | — |
NEW
|
10,644,340 | $1,818,691,932 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
TWST
Twist Bioscienc...
|
Healthcare | 2.54% | 33.14% |
#2
1
Prev: #1
|
2.5 |
—
|
-350,000 | -42.2% |
P
S
|
478,815 | $49,260,487 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TSLA
Tesla, Inc.
|
Consumer Cyclical | 1.87% | 26.98% |
#3
1
Prev: #2
|
2.7 |
—
|
no change | no change |
P
S
|
86,250 | $36,276,750 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
H
Hyatt Hotels Co...
|
Consumer Cyclical | 0.70% | 8.47% |
#4
1
Prev: #5
|
1.8 |
—
|
no change | no change |
P
S
|
70,000 | $13,568,800 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDGL
Madrigal Pharma...
|
Healthcare | 0.58% | 9.25% |
#5
1
Prev: #4
|
1.7 |
—
|
no change | no change |
P
S
|
21,000 | $11,275,950 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TXG
10x Genomics, I...
|
Healthcare | 0.56% | 3.77% |
#6
Prev: #6
|
2.7 |
—
|
72,607 | 34.4% |
P
S
|
283,469 | $10,868,201 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
WRBY
Warby Parker In...
|
Healthcare | 0.00% | 2.38% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-134,473 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MASS
908 Devices Inc...
|
Healthcare | 0.00% | 2.93% |
Sold All 😨
(Was: #7) |
0.0 |
—
|
-568,981 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OUST
Ouster, Inc.
|
Technology | 0.00% | 13.07% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-845,316 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-9 of 9 holdings